Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether any phase 2 or 3 clinical trials have been approved for the potential treatment of systemic amyloidosis or multiple myeloma.
Seven Phase 2 or 3 trials for systemic amyloidosis and 58 Phase 2 or 3 trials for multiple myeloma have been approved in the United Kingdom since 2004. Four trials for systemic amyloidosis and 41 trials for multiple myeloma are currently still ongoing.